|
TGFBRAP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.66519999997583E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.558000E-02 |
| Normal-vs-Stage2 |
1.956980E-04 |
| Normal-vs-Stage3 |
5.33799999979934E-07 |
| Normal-vs-Stage4 |
8.67220000255742E-08 |
| Stage1-vs-Stage2 |
1.681700E-02 |
| Stage1-vs-Stage3 |
3.238000E-04 |
| Stage1-vs-Stage4 |
5.59329999999525E-05 |
| Stage2-vs-Stage3 |
7.535000E-01 |
| Stage2-vs-Stage4 |
3.258600E-01 |
| Stage3-vs-Stage4 |
4.293000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.74659999999205E-06 |
| Normal-vs-AfricanAmerican |
1.867630E-02 |
| Normal-vs-Asian |
9.107800E-01 |
| Caucasian-vs-AfricanAmerican |
7.684200E-01 |
| Caucasian-vs-Asian |
2.196800E-01 |
| AfricanAmerican-vs-Asian |
3.712400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.74100000005506E-06 |
| Normal-vs-Female |
1.383650E-03 |
| Male-vs-Female |
1.747750E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.779600E-02 |
| Normal-vs-Age(41-60Yrs) |
5.759000E-04 |
| Normal-vs-Age(61-80Yrs) |
3.28839999996777E-06 |
| Normal-vs-Age(81-100Yrs) |
1.230190E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.133800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.837400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.026000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.282800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.759200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.111800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.159800E-01 |
| Normal-vs-Grade 2 |
2.863100E-03 |
| Normal-vs-Grade 3 |
1.93729999999892E-05 |
| Normal-vs-Grade 4 |
1.591099996201E-08 |
| Grade 1-vs-Grade 2 |
3.642200E-02 |
| Grade 1-vs-Grade 3 |
8.924600E-03 |
| Grade 1-vs-Grade 4 |
2.623600E-04 |
| Grade 2-vs-Grade 3 |
9.224000E-02 |
| Grade 2-vs-Grade 4 |
2.782600E-04 |
| Grade 3-vs-Grade 4 |
1.889520E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.622900E-03 |
| Normal-vs-ccB subtype |
3.601200E-04 |
| ccA subtype-vs-ccB subtype |
2.100400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.019150E-04 |
| Normal-vs-N1 |
3.408800E-01 |
| N0-vs-N1 |
8.518200E-01 |
|
|
